Trial Details

Not Recruiting
Basic Information
Clinical ID c3368
Identifier NL-OMON25485
Trial Title Tolerance and safety study of a new paediatric peptide feed.
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Children requiring a paediatric peptide feed for at least 8 weeks. This can be due to causes such as inflammatory bowel disease, short bowel syndrome, pancreas/liver disease, chronic diarrhoea, cystic fibrosis, undiagnosed gut problems, coeliac disease.
Interventions After baseline measurements, patients receive either their current feed (= control) for 4 weeks followed by 4 weeks paediatric peptide feed, or paediatric peptide feed for 4 weeks followed by 4 weeks on the control feed. After 4 weeks and after 8 weeks, children return to the clinic where the outcome measures are assessed. Children are invited to participate in an 3-month open extension of the study.
Participant Information
Sponsor Numico Research B.V.
City -
Country/Region -
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -